494 related articles for article (PubMed ID: 23067268)
1. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
2. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
[TBL] [Abstract][Full Text] [Related]
3. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
4. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
[TBL] [Abstract][Full Text] [Related]
6. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
7. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
Yang G; Hu F; Jia J
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
[TBL] [Abstract][Full Text] [Related]
8. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
9. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains.
Tinnert A; Mattsson A; Bölin I; Dalenbäck J; Hamlet A; Svennerholm AM
Microb Pathog; 1997 Nov; 23(5):285-96. PubMed ID: 9405206
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori CagA antigen antibodies].
Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of IgG antibody titer against Helicobacter pylori.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
[TBL] [Abstract][Full Text] [Related]
12. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
13. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
Atalay C; Atalay G; Altinok M
Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
[TBL] [Abstract][Full Text] [Related]
14. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM
Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247
[TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
[TBL] [Abstract][Full Text] [Related]
16. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
17. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
[TBL] [Abstract][Full Text] [Related]
18. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
[TBL] [Abstract][Full Text] [Related]
19. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]